Introduction: what changed — and what hasn’t (updated October 24, 2025)

All three allergy immunotherapy options—drops (SLIT liquid), shots (SCIT), and tablets (SLIT tablets)—desensitize your immune system to environmental allergens. The biggest 2025/2026 differences remain convenience, scope of allergens treated, cost/coverage, and safety profile—not core efficacy, which major reviews still consider comparable when dosed appropriately.

Key takeaways

• Effectiveness: Comparable across drops, shots, and tablets per systematic reviews and guidelines when properly selected/dosed. See the evidence sections and sources.

• Safety: SLIT (drops/tablets) has a lower severe reaction risk and is taken at home; SCIT requires clinic observation after injections.

• Scope: Drops can combine many allergens; tablets cover one allergen per product (currently grass, ragweed, or dust mite in the U.S.); shots can mix multiple allergens.

• Time to relief: Drops/tablets often 4 weeks–6 months; shots typically 6–12 months.

• Course length: Plan on 3–5 years for durable, often decades‑long benefit.

Side‑by‑side comparison (2025/2026)

Dimension	Allergy drops (SLIT liquid)	Allergy shots (SCIT)	Allergy tablets (SLIT tablets)
Where taken	At home, daily	In clinic; build‑up weekly, then maintenance	At home, daily
Allergens treated	Multi‑allergen mixes (pets, pollens, dust, molds)	Multi‑allergen mixes	Single allergen per tablet (grass, ragweed, dust mite)
FDA/regulatory (U.S.)	Uses FDA‑approved extracts; off‑label SLIT	FDA‑regulated extracts/injections	FDA‑approved SLIT tablets for specific allergens
Safety	Very low anaphylaxis risk; no office wait	Rare anaphylaxis risk; 30‑minute office observation required	Very low anaphylaxis risk; no office wait
Time to relief	~4 weeks–6 months	~6–12 months	~4 weeks–6 months
Course length	3–5 years	3–5 years	3–5 years
Convenience	Highest; no needles	Lowest; frequent clinic visits, injections	High; simple daily tablet
Cost/coverage (typical)	~$99/mo cash; HSA/FSA eligible; usually not insurance‑covered	Often insurance‑covered; total annual costs vary by plan and visit copays	Rx copay varies by plan; usually covered for approved allergens
Best for	Multi‑allergen profiles; needle‑averse; access or schedule constraints	Patients preferring in‑office care and insurance coverage	Single‑allergen (grass/ragweed/dust mite) with good Rx benefits

Sources:

How each option works

• Shots (SCIT): Gradual, supervised injections of allergen extracts to induce tolerance. Clinic observation reduces risk from rare systemic reactions.

• Drops (SLIT liquid): Daily micro‑doses under the tongue using FDA‑approved extracts and clinically proven dosing; at‑home, physician‑directed.

• Tablets (SLIT tablets): Daily, fixed‑dose tablets for one allergen (e.g., grass tablets); at‑home with prescription.

Efficacy evidence (what the literature and guidelines say)

• Systematic reviews and U.S. specialty guidelines continue to find SLIT and SCIT both effective for allergic rhinitis and related asthma when appropriately selected and dosed; choice can be preference‑ and access‑driven.

• Public‑health context: ~25.7% of U.S. adults report seasonal allergies; pollen seasons are lengthening with climate change, increasing the value of durable, disease‑modifying therapy.

Safety profile and monitoring

• SCIT: Must wait ~30 minutes after each injection due to rare but serious systemic reactions.

• SLIT (drops/tablets): Markedly lower severe‑reaction risk; most side effects are mild, local, and transient (e.g., mouth itch). Population risk estimates for severe reactions are far lower than with SCIT.

Cost and coverage in 2025/2026

• Shots: Commonly covered by insurance; patient costs depend on serum, visit copays/deductibles, and schedule. Annual out‑of‑pocket without coverage can reach the low thousands.

• Drops: Typically cash pay in the U.S. (no CPT billing for custom SLIT); HSA/FSA often eligible. Programs such as certain treatment plans run about $99/month and include ongoing clinician oversight.

• Tablets: Prescription copays vary; generally covered for FDA‑labeled allergens (grass, ragweed, dust mite).

Which one fits which patient?

• Choose drops if you: have multiple allergens (pets + pollens + dust/mold), prefer at‑home dosing, want to avoid needles/office time, and accept cash pricing.

• Choose tablets if you: are primarily allergic to one labeled allergen (grass, ragweed, or dust mite), have good Rx coverage, and prefer the simplicity of one pill/day.

• Choose shots if you: want in‑office escalation/monitoring, need multi‑allergen mixing with insurance coverage, and can commit to frequent clinic visits, especially during build‑up.

Practical timelines

• Initial improvement: SLIT drops/tablets often within 4–24 weeks; SCIT commonly 6–12 months.

• Durable benefit: Plan on 3 years (often up to 5) to “lock in” long‑term immune tolerance for all three.

Wyndly’s approach to SLIT (drops and tablets)

• Physician‑led care with at‑home testing (40+ environmental allergens) and personalized SLIT.

• Multi‑allergen drops for complex profiles; tablets when a single FDA‑labeled allergen dominates.

• Transparent pricing and 24/7 access.

FAQs

• Are drops, shots, and tablets equally effective?

• Yes—head‑to‑head meta‑evidence and guidelines support comparable effectiveness when properly selected and dosed; the best choice depends on allergens, access, and preferences.

• Can tablets treat more than one allergen at a time?

• Each tablet product treats one allergen (e.g., grass, ragweed, or dust mite). Multi‑allergen therapy typically requires drops or shots.

• Which is safest?

• All three are generally safe under medical oversight. SLIT (drops/tablets) has the lowest rate of severe systemic reactions; SCIT requires in‑office observation.

• How long until I feel better?

• SLIT drops/tablets: weeks to months (often by 3–6 months). SCIT: often 6–12 months. Full course ~3 years (sometimes up to 5) for sustained benefit.

• Will insurance cover it?

• Shots are often covered. Tablets are usually covered as prescriptions for labeled allergens. Custom SLIT drops are typically cash pay but HSA/FSA eligible.

---

Structured data (FAQ schema)

References and further reading

• Evidence and guidelines (SLIT/SCIT)

• Safety and monitoring

• Timelines and costs

• Population context

Note: Wyndly treats environmental allergies (not food) and typically serves patients ages 5+. Discuss personal risks, comorbid asthma, pregnancy, and medications (e.g., beta blockers) with your physician before starting any immunotherapy.